Variable | All patients (n = 46) | SH group (n = 15) | Non-SH group (n = 31) | P value |
---|---|---|---|---|
Postoperative serum Ca (mmol/L, x ± s) | 1.97 ± 0.17 | 1.77 ± 0.05 | 2.07 ± 0.11 |  < 0.001* |
Preoperative serum Ca (mmol/L, x ± s) | 2.85 ± 0.32 | 2.71 ± 0.22 | 2.93 ± 0.34 | 0.012* |
Decrease of serum Ca (mmol/L, x ± s) | 0.88 ± 0.33 | 0.94 ± 0.23 | 0.85 ± 0.37 | 0.362 |
Percentage decrease of serum Ca (%, x ± s) | 30.11 ± 9.03 | 34.07 ± 5.92 | 28.19 ± 9.71 | 0.037* |
iPTH [pg/mL, M(Q1, Q3)] | 461.7(174.8,887.7) | 802.4(247.9,1282) | 363(171.9,619.8) | 0.038* |
Serum P [mmol/L, M(Q1, Q3)] | 0.66(0.57,0.81) | 0.55(0.48,0.6) | 0.72(0.59,0.88) | < 0.001* |
Serum Ca/P (x ± s) | 4.37 ± 1.20 | 5.00 ± 0.99 | 4.07 ± 1.19 | 0.012* |
Urine Ca [mmol/24 h, M(Q1, Q3)] | 3.77(2.99,5.30) | 3.45(2.42,4.65) | 3.92(3.15,5.61) | 0.182 |
Urine P [mmol/24 h, M(Q1, Q3)] | 9.94(6.37,13.36) | 10.39(8.09,12.42) | 9.42(6.08,13.54) | 0.535 |
tP1NP [ng/mL, M(Q1, Q3)] | 144.6(73.2,310.7) | 257(146.8,549.3) | 104.2(66.57,251) | 0.007* |
βCTX [ng/mL, M(Q1, Q3)] | 1.30(0.59,1.97) | 1.82(0.89,2.29) | 1.01(0.57,1.82) | 0.185 |
OC [ng/mL, M(Q1, Q3)] | 106.5(33.3,161.9) | 156.5(96.7,238) | 58.2(29.9,141.3) | 0.013* |
25-(OH)-VD3 [ng/mL, M(Q1, Q3)] | 9.02(6.9,13.7) | 8.5(5.44,12.18) | 9.71(7.91,14.6) | 0.156 |
ALP [U/L, M(Q1, Q3)] | 167(86,332) | 296(209,553) | 117(80,231) | 0.002* |
Serum creatinine [μmol/L, M(Q1, Q3)] | 52(42,64) | 45(35,63) | 55(43,76) | 0.125 |
BUN [mmol/L, M(Q1, Q3)] | 4.05(3.2,5.225) | 4(2.8,5.3) | 4.1(3.6,5.2) | 0.392 |
Serum uric acid (μmol/L, x ± s) | 308.2 ± 89.1 | 314.53 ± 90.5 | 305.06 ± 89.71 | 0.739 |